We have been unable to confirm the report of Wolfe and Gatfield (3) that assay of ornithine transcarbamylase (OTC) in leukocytes can substitute for assay of this enzyme in a liver biopsy in order to make a diagnosis of ornithine transcarbamylase deficiency.
1 shows that urea cycle enzyme activities in the liver homogenates were within or close to the normal range except for OTC, which was IWO, 6%. and 13%, respectively, of the appropriate normal mean values (3). The white cell OTC activities bore no relationship to the liver deficiencies, being 150095, 98% and 1700% of the control mean value. One patient (S.B.) also had elevated values for carbamly phosphate synthetase and argininosuccinate lyase. while one (A.H.) had low values for argininosuccinate synthetase and lyase.
These results lead us to conclude that ornithine transcarbamylase deficiency in liver cannot be inferred from the results of tnis vo One unit equals 1 pmol product formed/hr; liver protein is milligrams per g wet wt; leukocyte protein is milligrams per ml of cell homogenate.
-60" for less than 3 days, thawed, 1.4 ml of distilled water added, enzyme's activity in peripheral leukocytes, but that liver biopsy is frozen and thawed three times and the cell suspension was ho-still necessary to confirm the diagnosis. Further correlations are mogenized with a Polytron tissue homogenizer for 15 sec. The necessary to conclude that liver deficiencies of the other enzymes urea cycle enzymes were assayed under conditions optimal for the can be detected in leukocytes. human enzymes (I). OTC and carbamyl phosphate synthetase assavs contained 0.1 ml of undiluted homogenate in the 0.3 ml were noted between fresh or frozen white cell pellets. The range the liver, which were frozen at -60" and assayed within 3 days. White cells were prepared as above and assayed in 3 days. Table Note: A rebuttal to this letter will be forthconring from D. At. Wolfe.
